Thermo Fisher Scientific Inc. (TMO)

263.81
NYSE : Health Technology
Prev Close 271.05
Day Low/High 263.61 / 269.85
52 Wk Low/High 199.85 / 271.70
Avg Volume 1.78M
Exchange NYSE
Shares Outstanding 399.00M
Market Cap 108.15B
EPS 7.30
P/E Ratio 37.44
Div & Yield 0.76 (0.26%)

Latest News

Thermo Fisher Scientific To Invest $150 Million To Expand Pharma Services Capabilities

Thermo Fisher Scientific To Invest $150 Million To Expand Pharma Services Capabilities

Expansion projects will increase capacity to meet growing customer demand for biologics

Thermo Fisher Scientific To Present At The Barclays Global Healthcare Conference On March 13, 2019

Thermo Fisher Scientific To Present At The Barclays Global Healthcare Conference On March 13, 2019

WALTHAM, Mass., March 4, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Increases Quarterly Dividend

Thermo Fisher Scientific Increases Quarterly Dividend

WALTHAM, Mass., Feb.

Investing Ideas for Extraction and Vape

Investing Ideas for Extraction and Vape

Valens GroWorks gains traction in rapidly growing space.

Torque And Thermo Fisher Scientific Announce Collaboration To Build State-of-the-Art Facility To Manufacture Torque's Deep-Primed T Cell Immunotherapies

Torque And Thermo Fisher Scientific Announce Collaboration To Build State-of-the-Art Facility To Manufacture Torque's Deep-Primed T Cell Immunotherapies

-Thermo Fisher's Princeton, NJ facility to come online in 2019 to support clinical development of Torque's expanding cellular immunotherapy pipeline -

Why Huawei Matters, FOMC Decision, AAPL Results, Watching NOW: Market Recon

Why Huawei Matters, FOMC Decision, AAPL Results, Watching NOW: Market Recon

I think we can all agree that there will be no increase made to the Fed Funds Rate today.

Gatan Acquisition Requires Further UK Review

Gatan Acquisition Requires Further UK Review

WALTHAM, Mass. and SARASOTA, Fla.

Thermo Fisher Shows Super Relative Strength - Go Long or Add to Longs

Thermo Fisher Shows Super Relative Strength - Go Long or Add to Longs

Let's check the charts and indicators.

Putting the Markets in Focus: Cramer's 'Mad Money' Recap (Thursday 11/15/18)

Putting the Markets in Focus: Cramer's 'Mad Money' Recap (Thursday 11/15/18)

Jim Cramer says perception is determining how stocks trade right now -- and there's a lot of negativity.

BP, Arconic, Fiat Chrysler: 'Mad Money' Lightning Round

BP, Arconic, Fiat Chrysler: 'Mad Money' Lightning Round

Jim Cramer take a closer look at BP, Arconic, Fiat Chrysler, Qualcomm, Thermo Fisher, GameStop, Arena Pharmaceuticals and more.

Bad News Is Good News: Cramer's 'Mad Money' Recap (Thursday 11/8/18)

Bad News Is Good News: Cramer's 'Mad Money' Recap (Thursday 11/8/18)

Cramer said the recent selloff has been good for investors because it reset expectations. Here's what he thinks about energy and the Fed.

Emerson Electric, Arista Networks, Foot Locker: 'Mad Money' Lightning Round

Emerson Electric, Arista Networks, Foot Locker: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Emerson Electric, Arista Networks, Foot Locker, SailPoint Technologies, Crown Holdings, Idexx Laboratories and more.

Thermo Fisher Scientific Declares Quarterly Dividend

Thermo Fisher Scientific Declares Quarterly Dividend

WALTHAM, Mass., Nov.

Thermo Fisher Scientific Elects New Director To Board

Thermo Fisher Scientific Elects New Director To Board

WALTHAM, Mass., Nov.

Thermo Fisher Scientific Opens Newly Expanded Facility In Frederick, Md.

Thermo Fisher Scientific Opens Newly Expanded Facility In Frederick, Md.

Site expansion helps high-tech center meet growing demand from global healthcare industry

The Truth About Trade: Cramer's 'Mad Money' Recap (Monday 9/17/18)

The Truth About Trade: Cramer's 'Mad Money' Recap (Monday 9/17/18)

Jim Cramer says Wall Street isn't very worried about tariffs. He highlights the stocks with China exposure and looks at the potential impact.

How to Trade Microsoft Into Earnings: Market Recon

How to Trade Microsoft Into Earnings: Market Recon

Add to longs near this key support level.

Thermo Fisher Scientific Reports Third Quarter 2018 Results

Thermo Fisher Scientific Reports Third Quarter 2018 Results

WALTHAM, Mass., Oct.

Thermo Fisher Scientific Moves Up In Analyst Rankings, Passing Boston Scientific

Thermo Fisher Scientific Moves Up In Analyst Rankings, Passing Boston Scientific

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Thermo Fisher Scientific Inc has taken over the #11 spot from Boston Scientific Corp. , according to ETF Channel.

Jim Cramer: Valuations Now Have No Relation to Common Sense

Jim Cramer: Valuations Now Have No Relation to Common Sense

Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.

TheStreet Quant Rating: A+ (Buy)